| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $83.1M | — | +38.3% |
| R&D Expense | $8.8M | — | +13.3% |
| SG&A Expense | $53.1M | — | +20.7% |
| Operating Income | $7.9M | — | +356.2% |
| Income Tax | $0 | — | — |
| Net Income | $2.2M | — | +124.2% |
| EPS (Basic) | $0.01 | — | +116.7% |
| EPS (Diluted) | $0.01 | — | +116.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $111.8M | +0.6% | +91.2% |
| Accounts Receivable | $56.3M | +10.3% | +21.5% |
| Inventory | $74.2M | +8.1% | +40.9% |
| Current Assets | $251.7M | +4.7% | +53.9% |
| Total Assets | $392.0M | +2.2% | +24.3% |
| Current Liabilities | $118.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $9.9M | — | +198.4% |
| Investing Cash Flow | -$325K | — | -2400.0% |
| Financing Cash Flow | -$8.8M | — | -181.7% |
| +24.7% |
| Long-term Debt | $221.2M | +0.4% | -3.7% |
| Total Liabilities | $379.0M | +2.5% | +8.1% |
| Stockholders' Equity | $13.0M | -5.0% | +137.0% |